Galvita develops a patented and clinically validated oral drug delivery platform. The microcapsules can be loaded with active ingredients from all BCS-classes as well as peptides, and can easily be compressed into ODTs with excellent mechanical strength and very fast disintegration.

Location

Canton

Facts & figures

  • Type of organization
    Private company
  • Year of foundation
    2020
  • Number of employees in Switzerland
    10-19

Keep browsing

You may also be interested in